Publications by authors named "Rich Erickson"

Claim this Profile
C
Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers.
Wenhui Zhang, Helen Tyrrell, Han Ting Ding, Jennifer Pulley, Audrey Boruvka, Rich Erickson

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease.
Gai Ayalon, Seung-Hye Lee, Oskar Adolfsson, Corinne Foo-Atkins, Jasvinder K Atwal, Rich Erickson

Sci Transl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease.
Charlotte Lichnog, Sha Klabunde, Emily Becker, Franklin Fuh, Philipp Tripal, Rich Erickson

Front Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury.
Michael E Rothenberg, Yehong Wang, Annemarie Lekkerkerker, Dimitry M Danilenko, Romeo Maciuca, Rich Erickson

Clin Pharmacol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of IL-17AA and IL-17FF as Pharmacodynamic Biomarkers to Demonstrate Target Engagement in the Phase I Study of MCAF5352A.
Kun Peng, Yehong Wang, Ketevan Siradze, Rich Erickson, Saloumeh K Fischer

AAPS J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.
Xiaohui Wei, Leonid Gibiansky, Yehong Wang, Franklin Fuh, Rich Erickson

J Clin Pharmacol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology.
Kathi Williams, Rich Erickson, Saloumeh Kadkhodayan Fischer

Bioanalysis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.
Kun Peng, Keyang Xu, Luna Liu, Robert Hendricks, Reginald Delarosa, Rich Erickson

MAbs· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing design of experiments to characterize assay robustness.
Kyra J Cowan, Rich Erickson, Brian Sue, Reginald Delarosa, Bert Gunter

Bioanalysis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma.
Laura A Strickland, Jed Ross, Simon Williams, Sarajane Ross, Maria Romero, Rich Erickson

J Pathol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis